Radiation therapy is a standard therapeutic option in the post-operative setting for early breast cancer patients after breast conserving surgery, providing a substantial benefit in reducing the risk of local relapse with a consequent survival gain. Nevertheless, the reduction in the burden related to treatment is becoming crucial in modern oncology for both local and systemic therapies and investigational efforts are being put forward by radiations oncologists to identify a subset of women at very low risk to be potentially omitted from post-operative irradiation after breast conservation. Clinical factors, classical pathological parameters and new predictive scores derived from gene expression and next generation sequencing techniques are being integrated in the quest toward a reliable low-risk profile for breast cancer patients. We herein provide a comprehensive overview on the topic. (C) 2020 Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.

Omission of postoperative radiation after breast conserving surgery: A progressive paradigm shift towards precision medicine / Franco, Pierfrancesco; De Rose, Fiorenza; De Santis, Maria Carmen; Pasinetti, Nadia; Lancellotta, Valentina; Meduri, Bruno; Meattini, Icro. - In: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. - ISSN 2405-6308. - STAMPA. - 21:(2020), pp. 112-119. [10.1016/j.ctro.2020.02.003]

Omission of postoperative radiation after breast conserving surgery: A progressive paradigm shift towards precision medicine

Meattini, Icro
2020

Abstract

Radiation therapy is a standard therapeutic option in the post-operative setting for early breast cancer patients after breast conserving surgery, providing a substantial benefit in reducing the risk of local relapse with a consequent survival gain. Nevertheless, the reduction in the burden related to treatment is becoming crucial in modern oncology for both local and systemic therapies and investigational efforts are being put forward by radiations oncologists to identify a subset of women at very low risk to be potentially omitted from post-operative irradiation after breast conservation. Clinical factors, classical pathological parameters and new predictive scores derived from gene expression and next generation sequencing techniques are being integrated in the quest toward a reliable low-risk profile for breast cancer patients. We herein provide a comprehensive overview on the topic. (C) 2020 Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.
2020
21
112
119
Franco, Pierfrancesco; De Rose, Fiorenza; De Santis, Maria Carmen; Pasinetti, Nadia; Lancellotta, Valentina; Meduri, Bruno; Meattini, Icro
File in questo prodotto:
File Dimensione Formato  
PIIS2405630820300094.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Creative commons
Dimensione 1.61 MB
Formato Adobe PDF
1.61 MB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1196216
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 28
social impact